Form4.ai tracks every SEC insider trade in real time. See every OTLK insider filing with a free account — no card.
See every OTLK insider filing — free account, no card.
Free accountOutlook Therapeutics, Inc. (OTLK) has 4 SEC Form 4 insider filings on record in the last 90 days. That includes 3 insider purchases totalling $2.5M. Most recent filing: Sept. 2, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Aug 14, 2026 SEC filing | Jahr Robert Charles Chief Executive Officer | Bought | — | — |
| Aug 14, 2026 SEC filing | Sukhtian Ghiath M. Director | Bought | $2,499,999 | -33.3% 30D |
| Aug 14, 2026 SEC filing | KENYON LAWRENCE A Chief Financial Officer | Bought | — | — |
Create a free account to see all 4 OTLK filings from the last 90 days. No card needed.
Create free accountWant OTLK insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.